We're moving to Bluesky! ✈️🔵
Our lab will now share updates on Bluesky instead of X. Please consider following us to stay connected! You will continue to be able to find our updates via our website and on Hanns' LinkedIn account.
👉Follow us here: bsky.app/profile/lochmullerl…
ALT Text reading: We are moving to bluesky! We're now active on Bluesky! We invite you to follow us at @lochmullerlab.org to stay updated on news from our clinical and translational research lab! Lochmuller lab logo under text, with screenshot of bluesky profile page on the right of graphic.
We're moving to Bluesky! 🧳🔵
The #NMD4C will now share updates on Bluesky instead of X. Please consider following us to stay connected! You will continue to be able to find our updates via our accounts on LinkedIn and Facebook.
👉Follow us here: bsky.app/profile/nmd4c.ca
ALT Text reading NMD4C joins bluesky - We're now active on Bluesky! We invite you to follow us at @nmd4c.ca to stay updated on news from our Canadian neuromuscular network. NMD4C and bluesky logo, with an image of the NMD4C bluesky feed.
The NMD4C Basic Research Summer School is back for a second year! Get ready to level up your neuromuscular research skills with hands-on workshops, expert lectures, and career-building networking🚀
📍York University @MHRC_YorkU
🗓️May 7-8, 2025
Apply at: neuromuscularnetwork.ca/basi…
📢New research paper from our lab!
🔍To address the need for novel therapeutic strategies for Riboflavin Transporter Deficiency, we developed a #zebrafish model for use in therapeutic screening of #riboflavin and candidate therapeutics.
Full story: lochmullerlab.org/t5d3New
ALT New lab publication - development of a riboflavin-response model of riboflavin transporter deficiency in zebrafish
🔬 Early-career neuromuscular researchers: your work deserves recognition!
Apply for our #Biomedical Researcher of the Year Award to celebrate your outstanding achievements & contributions in basic NM science.
📄 Apply now: bit.ly/4e1mAS1
📅Deadline: Jan 15, 2025
📩 The December 2024 issue of the NMD4C newsletter is now available!
✨See the latest updates from the network - plus community events, new research, opportunities and more!
Available online at: zc.vg/KRPrU?m=0@MD_Canada@CIHR_IMHA@CanadianRDN
ALT The December NMD4C newsletter is here! Read the latest updates from the network plus opportunities, events and more!
ALT Congratulations Eric Poulin Centre for Neuromuscular Disease, celebrating 25 years of neuromuscular research. Photo including all current and former Centre leaders.
🌟 Exciting News! A breakthrough has identified genetic mutations in the TRiC chaperonin complex, linked to severe brain malformations providing new hope for diagnosis and treatment. This research is led by Dr. Hanns Lochmuller in Canada.
Learn more: canadianrdn.ca/new-genetic-d…
🔎Are you a CDN neuromuscular research trainee? This opportunity is for you!
✨Apply to join our new Basic Science Trainee Committee (BSTC) to represent the interests of NM trainees and build your leadership skills and professional network.
Apply here➡️ neuromuscularnetwork.ca/BSTC…
📢Welcome to join us for the last talk of this year! Dr. Stephanie Tobin will be sharing her fascinating research on “Decoding Muscle Loss: Cardiac Cachexia, tRNA Dysregulation, and Muscle Atrophy Pathways”. 🗓️Join us virtually on Monday, Nov. 25th from 2 to 3 pm #ScienceTwitter
Our clinical research team at the #NeuroMuscular centre of @OttawaHospital is excited to share that a Canadian patient affected by DOK-7 CMS is the first patient world-wide to receive a dose of a novel trial medicine for this condition!🌎
Full story➡️ lochmullerlab.org/Dok7-CMS-s…
ALT Clinical trial update - Canadian Patient First in the World to Receive Trial Drug in Argenx DOK7-CMS Study
Exciting new publication from the lab, led by Dr Ingo Kurth and his team from Germany, shows alterations in the TRiC chaperonin complex may play a pivotal role in a new group of severe brain conditions now known as TRiCopathies!🧬 @kinnudreamz@ConnectRD
🔎bit.ly/3Azwcpf
🎉We are delighted to share exciting news from the uOttawa Brain and Mind Research Institute (@uOttawaBMRI) that Dr Hanns Lochmüller and Dr @MireilleKhacho have been appointed as the new leaders of the Neuromuscular Health research hub!
ALT New leadership for the University of Ottawa Centre for Neuromuscular Disease, Drs Mireille Khacho and Hanns Lochmuller.
📢Don't miss this new webinar series from @euro_nmd! We're looking forward to attending the 9-episode series exploring #MuscleBiopsies, running from November to January.
More information 👇
🚀 Exciting news! #EURONMD Neuromuscular Pathology Webinar Series kicks off in early November! Join us for a 9-episode journey into #MuscleBiopsies, packed with insights, techniques & the latest in neuromuscular pathology.🧬
➡️More info here: bit.ly/3YJtMxK
Congratulations to lab members Kelly Ho & Dr Lola Lessard, who recently received research poster awards at major national and international conferences! bit.ly/4e4SblI
🏅Kelly: @WorldMuscleSoc Elsevier Runner Up Award
🏅Dr Lessard: @WCNMConference Best Research Poster
ALT Kelly Ho and Dr Lola Lessard receive Elsevier Runner Up Award at WMS and Best Research Poster at WCNMC
Last week NMD4C received the Excellence in Service Delivery Award from @MD_Canada! 🏅We are honored to receive this award and are excited to continue working with MDC and the Canadian neuromuscular community towards our goals. Learn more here➡️ bit.ly/4e1mAS1@CIHR_IMHA
🏅 The 2025 NMD4C Early-Career Awards are here! Apply for one of three prestigious awards honoring excellence in neuromuscular research to gain recognition and strengthen your academic profile!
Apply today at: bit.ly/4eVBoCQ#EarlyCareerAwards#ResearchExcellence
What a wonderful opportunity to celebrate Nigel's immense and ongoing contribution to the field. Congratulations Nigel and thanks to @Gianina_Natoli and team for organising!